SMi Group Ltd

Future Armoured Vehicles Survivability 2015, taking place on the 23rd & 24th November 2015 in London, will address recent industry developments to help you optimise armoured vehicle platforms for maximum protection.

SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will feature an array of case studies from major global pharma companies including MSD, Sanofi, GSK and more.

SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on 5-6 October 2015 in London, will address market access challenges and details how to overcome them with case studies from MSD, Sanofi, GSK and more.

Future Armoured Vehicles Survivability 2015, taking place on 23-24 November 2015 in London, will address recent industry developments to help you optimise armoured vehicle platforms for maximum protection.

SMi's 21st annual European Pharmaceutical Pricing and Reimbursement conference, taking place on 5-6 October 2015 in London, will address market access challenges and details how to overcome them.

This year's conference will address the impact of Biosimilars and Orphan Drugs on P&R, Case Studies in Reforms, Purchasing Mechanisms and Working with Payers.

SMi's European Pharmaceutical Pricing & Reimbursement conference, taking place on 5-6 October 2015 in London, will feature an array of case studies from pharma companies including MSD, Sanofi, GSK and more.

This year's conference will address the impact of Biosimilars and Orphan Drugs on P&R, Case Studies in Reforms, Purchasing Mechanisms and Working with Payers.

SMi’s 6th annual Biosimilars and Biobetters conference, taking place 30th September - 1st October 2015 in London, will address regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access and global market developments.

SMi's 6th annual Biosimilars and Biobetters conference, taking place on 30 September - 1 October 2015 in London, will address recent regulatory updates, pharmacovigilance of biosimilars, patent litigation, market access & global market developments.